- Home
- LATAW vs FBIOP Comparison
LATAW vs FBIOP Comparison
Compare LATAW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LATAW
- FBIOP
- Stock Information
- Founded
- LATAW N/A
- FBIOP N/A
- Country
- LATAW United States
- FBIOP United States
- Employees
- LATAW N/A
- FBIOP 101
- Industry
- LATAW Blank Checks
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- LATAW Finance
- FBIOP Health Care
- Exchange
- LATAW Nasdaq
- FBIOP Nasdaq
- Market Cap
- LATAW N/A
- FBIOP N/A
- IPO Year
- LATAW 2025
- FBIOP N/A
- Fundamental
- Price
- LATAW $0.50
- FBIOP $6.54
- Analyst Decision
- LATAW
- FBIOP
- Analyst Count
- LATAW 0
- FBIOP 0
- Target Price
- LATAW N/A
- FBIOP N/A
- AVG Volume (30 Days)
- LATAW N/A
- FBIOP N/A
- Earning Date
- LATAW N/A
- FBIOP N/A
- Dividend Yield
- LATAW N/A
- FBIOP N/A
- EPS Growth
- LATAW N/A
- FBIOP N/A
- EPS
- LATAW N/A
- FBIOP N/A
- Revenue
- LATAW N/A
- FBIOP N/A
- Revenue This Year
- LATAW N/A
- FBIOP N/A
- Revenue Next Year
- LATAW N/A
- FBIOP N/A
- P/E Ratio
- LATAW N/A
- FBIOP N/A
- Revenue Growth
- LATAW N/A
- FBIOP N/A
- 52 Week Low
- LATAW N/A
- FBIOP N/A
- 52 Week High
- LATAW N/A
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- LATAW N/A
- FBIOP 40.38
- Support Level
- LATAW N/A
- FBIOP $6.27
- Resistance Level
- LATAW N/A
- FBIOP $7.09
- Average True Range (ATR)
- LATAW 0.00
- FBIOP 0.30
- MACD
- LATAW 0.00
- FBIOP 0.04
- Stochastic Oscillator
- LATAW 0.00
- FBIOP 36.59
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.